Sam Russo
Neurology with Special Qualifications in Child Neurology · Houston, TXNPI 1023468733
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by UCB, Inc. at 38.6% of the total.
Across 89 payments — averaging $27.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$948
- Jazz Pharmaceuticals Inc.$349
- Biogen$210
- Amgen$143
- Sanofi$122
- Acadia Pharmaceuticals Inc$86
- plus $595 from 14 others
Across 7 payments — averaging $2182.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$15K
What the payments were for
- Speaking & faculty fees$432%
- Food & beverage$2,41198%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 27 | $948 |
| Jazz Pharmaceuticals Inc. | 12 | $349 |
| Biogen | 8 | $210 |
| Amgen | 8 | $143 |
| Sanofi | 1 | $122 |
| Acadia Pharmaceuticals Inc | 4 | $86 |
| Neurocrine Biosciences, Inc. | 3 | $81 |
| Upsher-smith Laboratories LLC | 3 | $78 |
| Immedica Pharma US, Inc. | 3 | $71 |
| PTC Therapeutics, Inc. | 2 | $56 |
| SK Life Science, Inc. | 2 | $53 |
| Aucta Pharmaceuticals, Inc. | 6 | $46 |
| Acorda Therapeutics, Inc | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Eisai Inc. | 1 | $25 |
| Bioventus LLC | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Aprecia Pharmaceuticals, LLC | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Neurelis, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,455 in reported general payments places this provider in the 65th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Houston
- Huda ZoghbiHouston$5.5M
- Shade MoodyHouston$194K
- Mary Kay KoenigHouston$171K
- Gretchen von AllmenHouston$31K
- Victoria HardwickHouston$10K
- Joshua RotenbergHouston$9K
- Mered ParnesHouston$5K
- Sarah WilsonHouston$5K
- Roy EltermanDallas$5.9M
- Diana CastroDenton$343K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.